BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 210,587,372
- Total 13F shares
- 212,399,050
- Share change
- +12,841,855
- Total reported value
- $1,656,166,055
- Put/Call ratio
- 72%
- Price per share
- $7.80
- Number of holders
- 272
- Value change
- +$103,754,636
- Number of buys
- 132
- Number of sells
- 156
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
21,790,881
|
$165,392,786 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.4%
from 13D/G
|
21,245,876
|
$161,256,203 | — | 30 Sep 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
7.3%
|
15,302,186
|
$116,143,592 | $0 | 04 Nov 2025 | |
| James E. Flynn |
13D/G
|
Deerfield Mgmt, L.P. |
6.8%
|
14,341,000
|
$109,278,420 | +$16,550,640 | 31 Dec 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
5.8%
|
12,169,000
|
$92,362,710 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
5.3%
|
11,073,211
|
$84,377,868 | $0 | 31 Dec 2025 | |
| Avoro Capital Advisors LLC |
13D/G
13F
|
Company |
4.2%
|
8,700,000
|
$71,514,000 | $0 | 31 Mar 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
4.5%
|
9,390,270
|
$71,272,149 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
2.8%
|
5,967,737
|
$45,295,124 | — | 30 Sep 2025 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.6%
|
5,464,021
|
$41,471,919 | — | 30 Sep 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
2.5%
|
5,225,986
|
$39,665,234 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
5,202,959
|
$39,490,462 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
5,052,307
|
$38,353,050 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
2.1%
|
4,419,629
|
$33,544,984 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2%
|
4,240,712
|
$32,187,004 | — | 30 Sep 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.7%
|
3,620,261
|
$27,477,781 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.7%
|
3,617,882
|
$27,459,724 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.5%
|
3,092,592
|
$23,472,773 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
2,711,806
|
$20,582,607 | — | 30 Sep 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.3%
|
2,632,696
|
$19,982,161 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.1%
|
2,410,362
|
$18,294,648 | — | 30 Sep 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1%
|
2,197,765
|
$16,681,000 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1%
|
2,140,534
|
$16,246,653 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.99%
|
2,094,278
|
$15,895,570 | — | 30 Sep 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.98%
|
2,055,915
|
$15,604,395 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.95%
|
1,994,404
|
$15,137,526 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.9%
|
1,902,819
|
$14,442,397 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.9%
|
1,892,043
|
$14,360,607 | — | 30 Sep 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.89%
|
1,880,389
|
$14,272,153 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.88%
|
1,848,346
|
$14,028,946 | — | 30 Sep 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.87%
|
1,822,992
|
$13,836,510 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.81%
|
1,709,336
|
$12,973,860 | — | 30 Sep 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.65%
|
1,373,625
|
$10,425,814 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.65%
|
1,359,882
|
$10,321,505 | — | 30 Sep 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.59%
|
1,246,696
|
$9,462,419 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.57%
|
1,196,319
|
$9,033,371 | — | 30 Sep 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.54%
|
1,134,813
|
$8,613,231 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.54%
|
1,132,377
|
$8,594,742 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.53%
|
1,108,660
|
$8,414,729 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.51%
|
1,069,015
|
$8,113,824 | — | 30 Sep 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.48%
|
1,012,664
|
$7,686,120 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.47%
|
999,785
|
$7,588,369 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.46%
|
962,376
|
$7,304,434 | — | 30 Sep 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
957,021
|
$7,263,789 | — | 30 Sep 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.44%
|
924,776
|
$7,019,050 | — | 30 Sep 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.43%
|
901,500
|
$6,842,385 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.4%
|
848,562
|
$6,440,586 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.4%
|
839,403
|
$6,363,000 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.38%
|
800,000
|
$6,072,000 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.37%
|
782,232
|
$5,937,141 | — | 30 Sep 2025 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q4 2025
As of 31 Dec 2025,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
272 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
212,399,050 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., STATE STREET CORP, Kynam Capital Management, LP, JANUS HENDERSON GROUP PLC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
272
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
282
Q4 2025 holders
272
Holder diff
-10
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.